SMALL LYMPHOCYTIC LEUKEMIA
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancers
Disease control CompletedThis first-in-human study tested a new oral drug called BR101801 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early s…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Doctors test hitting leukemia early in High-Risk patients
Disease control CompletedThis study tested if starting a drug called ibrutinib earlier could better control a type of blood cancer called chronic lymphocytic leukemia (CLL) in patients who are at high risk for the disease getting worse but don't yet have symptoms. The usual approach is to wait until symp…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC
-
Researchers map the uncertain path after leukemia drugs fail
Knowledge-focused CompletedThis study looked back at the medical records of 152 adults with chronic lymphocytic leukemia (CLL) to understand what happens after two common types of oral medications stop working. The goal was to see what treatments doctors tried next and how patients responded, because there…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC